Canaloplasty microcatheter receives clearance
iScience Interventional has been granted 510k clearance from the FDA for its canaloplasty microcatheter for the catheterization and viscodilation of the Schlemm's canal in adult patients with primary open-angle glaucoma (POAG).
iScience Interventional has been granted 510k clearance from the FDA for its canaloplasty microcatheter for the catheterization and viscodilation of the Schlemm's canal in adult patients with primary open-angle glaucoma (POAG).
Canaloplasty, a minimally-invasive surgical technique, uses a 250 micron microcatheter to access the drainage channels and enlarge them allowing the canal to function normally again, thus lowering intraocular pressure (IOP).
Michael Nash, President of iScience Interventional, commented, "Microcatheters represent an exciting new frontier for ophthalmology. We believe that interventional procedures will significantly alter the paradigm for a wide range of eyes diseases and disorders in the future."
